Every material Form 8-K Pilgrim's Pride filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Pilgrim's Pride reported third quarter 2025 results for the period ended September 28, 2025, with net sales up 3.8% year over year to $4.8 billion. GAAP earnings per share fell 2.0% to $1.44 and operating income fell 3.1% to $492.6 million, while Adjusted EBITDA declined 4.1% to $633.1 million. For shareholders, higher sales were offset by lower quarterly profit measures, though nine-month GAAP EPS rose 16.5% to $4.17.
Third quarter net sales were $4,759.3 million, up 3.8% from $4,585.0 million a year earlier.
GAAP EPS was $1.44 versus $1.47 in the prior-year quarter, a decline of 2.0%; adjusted EPS was $1.52.
Adjusted EBITDA was $633.1 million, a 13.3% margin, compared with $660.4 million and a 14.4% margin a year earlier.
Nine-month GAAP EPS rose 16.5% to $4.17, and net leverage was approximately 1.0 times Adjusted EBITDA.
Pilgrim's Pride reported second-quarter 2025 net sales of $4.8 billion, up 4.3% from a year earlier, and GAAP EPS of $1.49 versus $1.37. The board also declared a $2.10 per share dividend, which the company says totals about $500 million, payable to holders of record on August 20, 2025.
Net sales were $4,757.4 million, up 4.3% from $4,559.3 million in the second quarter of 2024.
GAAP EPS was $1.49, up from $1.37; operating income was $512.3 million, up 16.2%.
The board declared a $2.10 per share dividend, about $500 million in total, to stockholders of record at the close of business on August 20, 2025.
Management will hold a conference call on July 31, 2025 at 7 a.m. MT (9 a.m. ET).
At its April 30, 2025 annual meeting, Pilgrim's Pride stockholders elected all ten director nominees, approved an advisory say-on-pay vote, ratified KPMG LLP as auditor for fiscal 2025, and approved the Amended and Restated 2019 Long Term Incentive Plan, which increases the number of shares authorized for issuance under the plan. The filing contains no financial results, and the plan change adds equity compensation capacity that shareholders approved.
Annual meeting held April 30, 2025; all ten director nominees elected
Say-on-pay advisory vote approved, with 217,528,144 votes for and 11,277,057 against
KPMG LLP ratified as independent auditor for fiscal year ending December 28, 2025, with 228,933,354 votes for
Restated 2019 LTIP approved with 228,051,261 votes for and 765,324 against; plan effective on approval
Pilgrim's Pride reported first quarter 2025 results with net sales of $4.5 billion, up 2.3% from a year earlier, and GAAP diluted EPS of $1.24 versus $0.73. Operating income rose 61.6% to $404.5 million, and the company paid a special dividend of $1.5 billion, leaving a net leverage ratio of 1.1x of Adjusted EBITDA for shareholders to weigh.
Net sales were $4,463.0 million, up 2.3% from $4,361.9 million in the first quarter of 2024.
GAAP diluted EPS was $1.24, compared with $0.73; GAAP net income attributable to the company was $296.0 million.
Operating income was $404.5 million, up 61.6%, and Adjusted EBITDA was $533.2 million, a 12.0% margin.
The special dividend of $1.5 billion was payable at quarter end, and the net leverage ratio was 1.1x, versus a target of 2x to 3x.
Pilgrim's Pride reported fourth-quarter 2024 net sales of $4.4 billion, down 3.5% from the prior-year quarter, while GAAP diluted EPS rose to $0.99 from $0.57. For the full year, net sales rose 3.0% to $17.9 billion and GAAP diluted EPS rose to $4.57 from $1.36, so profit grew faster than sales in both periods.
Q4 2024 net sales were $4.4 billion, down 3.5%; the prior-year quarter had 14 weeks, per the filing's footnote.
Q4 GAAP net income was $235.9 million, with diluted EPS of $0.99 versus $0.57 a year earlier.
Q4 Adjusted EBITDA was $525.7 million, a 12.0% margin, up from $309.5 million (6.8%) a year earlier.
Full-year 2024 net sales were $17.9 billion, up 3.0%, and GAAP net income was $1.1 billion; a conference call is set for Feb. 13, 2025 at 7 a.m. MT.
Pilgrim's Pride added Joanita Karoleski to its Board of Directors as a JBS Director on February 4, 2025, and re-appointed Mr. Menon, reclassifying him from an Equity Director to a JBS Director. The Board said the appointments were made to meet a requirement in the company's charter and bylaws on the total number of directors and JBS Directors, following stockholder approval at the December 2024 special meeting. The filing describes both directors as independent and says neither is expected to serve on committees.
Joanita Karoleski appointed to the Board as a JBS Director on February 4, 2025; she previously served as a director from 2022 until early 2024
Mr. Menon re-appointed to the Board and re-classified from Equity Director to JBS Director; he has served as a director since 2021
Both directors determined to be independent under Nasdaq Rule 5605(a)(2) and Rule 10A-3
Both will receive non-employee director compensation under the program described in the April 1, 2024 proxy statement
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Pilgrim's Pride filing is on SEC EDGAR ↗. 8-K briefs of other companies →